New study aims to improve quality of life for older bladder cancer patients
NCT ID NCT06138561
First seen Feb 18, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This study looks at two treatment options for people aged 65 and older with advanced bladder cancer who cannot take the chemotherapy drug cisplatin. Researchers want to see which treatment better maintains quality of life and causes fewer side effects. Participants will receive either a carboplatin-based chemotherapy followed by immunotherapy, or a combination of enfortumab vedotin and pembrolizumab. The study also tests whether a simple geriatric questionnaire can help predict how well patients will handle their treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.